Find information on thousands of medical conditions and prescription drugs.

Lupron

Leuprolide is a gonadotropin-releasing hormone agonist (GnRH agonist). By causing constant stimulation of the pituitary GnRH receptors, it intially causes stimulation (flare), but thereafter decreases pituitary secretion (downregulation) of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
Labetalol
Lacrisert
Lactitol
Lactuca virosa
Lactulose
Lamictal
Lamisil
Lamivudine
Lamotrigine
Lanophyllin
Lansoprazole
Lantus
Lariam
Larotid
Lasix
Latanoprost
Lescol
Letrozole
Leucine
Leucovorin
Leukeran
Levaquin
Levetiracetam
Levitra
Levocabastine
Levocetirizine
Levodopa
Levofloxacin
Levomenol
Levomepromazine
Levonorgestrel
Levonorgestrel
Levophed
Levora
Levothyroxine sodium
Levoxyl
Levulan
Lexapro
Lexiva
Librium
Lidocaine
Lidopen
Linezolid
Liothyronine
Liothyronine Sodium
Lipidil
Lipitor
Lisinopril
Lithane
Lithobid
Lithonate
Lithostat
Lithotabs
Livostin
Lodine
Loestrin
Lomotil
Loperamide
Lopressor
Loracarbef
Loratadine
Loratadine
Lorazepam
Lortab
Losartan
Lotensin
Lotrel
Lotronex
Lotusate
Lovastatin
Lovenox
Loxapine
LSD
Ludiomil
Lufenuron
Lupron
Lutropin alfa
Luvox
Luxiq
Theophylline
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Like other GnRH agonists, leuprolide may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, estrogen-dependent conditions (such as endometriosis or uterine fibroids), to treat precocious puberty, and to control ovarian stimulation in IVF.

Leuprolide acetate is marketed by Bayer AG under the brand name Viadur, by Sanofi-Aventis under the brand name Eligard, and by TAP Pharmaceuticals under the brand name Lupron.

Read more at Wikipedia.org


[List your site here Free!]



Tap pharmaceuticals will pay $875 million in lupron case - Pharmacy Watch - Brief Article
Tap pharmaceuticals will pay $875 million in lupron case. (Pharmacy Watch).
Failed IVF may be due to defective uterine receptivity, inflammation - Treat with Lupron, Laser Surgery
ASHEVILLE, NC. -- Ongoing research on the process of implantation suggests that those women who have the most difficulty becoming pregnant may have defects in uterine receptivity, Dr. Bruce A. Less
The truth about fibroids: our guide to the latest in treatment - health
Kimberly Reid had always had fairly regular periods. But over the course of a year and a half, the 34-year-old realized her four-to-five-day periods ...
Protect your fertility: what you can do now to safeguard your chances of motherhood later - Reproductive Health
Have you noticed? All it takes to ruin a good night out or turn a book group into a heated debate are two words: biological clock For us women, that ...
Testosterone Replacement Therapy for Female Androgen Insufficiency Syndrome
The two case reports highlighted in this article illustrate that, although its diagnosis can sometimes be challenging, the female androgen insufficiency ...
Pharmaceutical: top 50 packages
PHARMACEUTICAL
IN THE NEWS
UN passes declaration favoring human cloning ban The United Nations recently passed a declaration opposing all forms of human cloning as "incompatible ...
GnRH agonist may curb ovarian failure in lupus
SNOWMASS, COLO. -- A gonadotropin-releasing hormone agonist can prevent ovarian failure in lupus patients on cyclophosphamide, according to a small, ...

Home Contact Resources Exchange Links ebay